John Ginis

540 total citations
9 papers, 306 citations indexed

About

John Ginis is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, John Ginis has authored 9 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Microbiology and 2 papers in Immunology. Recurrent topics in John Ginis's work include Pneumonia and Respiratory Infections (8 papers), Bacterial Infections and Vaccines (7 papers) and Influenza Virus Research Studies (3 papers). John Ginis is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Bacterial Infections and Vaccines (7 papers) and Influenza Virus Research Studies (3 papers). John Ginis collaborates with scholars based in United States, United Kingdom and Belgium. John Ginis's co-authors include Daniel A. Scott, William C. Gruber, Wendy Watson, Joseph M. Severs, Ingrid L. Scully, Kathrin U. Jansen, Michael W. Pride, Carl Griffin, Allison Thompson and Sanela Tarabar and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Vaccine.

In The Last Decade

John Ginis

9 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ginis United States 6 278 150 26 26 21 9 306
Seyi Eletu United Kingdom 8 298 1.1× 96 0.6× 23 0.9× 18 0.7× 27 1.3× 19 322
Josefina Carlos Philippines 6 216 0.8× 206 1.4× 50 1.9× 28 1.1× 12 0.6× 10 272
May ElSherif Canada 8 154 0.6× 83 0.6× 38 1.5× 36 1.4× 16 0.8× 16 197
Magali Traskine Belgium 12 397 1.4× 268 1.8× 28 1.1× 18 0.7× 30 1.4× 18 440
Paola Vacca Italy 12 225 0.8× 254 1.7× 29 1.1× 28 1.1× 25 1.2× 35 309
Judith Spijkerman Netherlands 9 487 1.8× 257 1.7× 33 1.3× 20 0.8× 21 1.0× 10 522
Kumaran Vadivelu United States 8 259 0.9× 284 1.9× 34 1.3× 36 1.4× 12 0.6× 13 335
Helena Aparecida Barbosa Brazil 4 310 1.1× 293 2.0× 32 1.2× 14 0.5× 26 1.2× 5 337
Raydel Anderson United States 10 188 0.7× 111 0.7× 44 1.7× 52 2.0× 26 1.2× 15 244
Aly Drabo Burkina Faso 9 348 1.3× 334 2.2× 42 1.6× 9 0.3× 39 1.9× 15 402

Countries citing papers authored by John Ginis

Since Specialization
Citations

This map shows the geographic impact of John Ginis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ginis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ginis more than expected).

Fields of papers citing papers by John Ginis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ginis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ginis. The network helps show where John Ginis may publish in the future.

Co-authorship network of co-authors of John Ginis

This figure shows the co-authorship network connecting the top 25 collaborators of John Ginis. A scholar is included among the top collaborators of John Ginis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ginis. John Ginis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cannon, Kevin, José F. Cardona, Kari Yacisin, et al.. (2023). Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial. Vaccine. 41(13). 2137–2146. 12 indexed citations
2.
Beeslaar, Johannes, Judith Absalon, Annaliesa S. Anderson, et al.. (2020). MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infectious Diseases and Therapy. 9(3). 641–656. 4 indexed citations
3.
Griffin, Carl, Daniel A. Scott, Michael W. Pride, et al.. (2020). 1240. Persistence of Circulating Antibody Through 12 Months Following Vaccination With a 20-Valent Pneumococcal Conjugate Vaccine in Adults 60–64 Years of Age. Open Forum Infectious Diseases. 7(Supplement_1). S639–S639. 1 indexed citations
4.
Griffin, Carl, Daniel A. Scott, Michael W. Pride, et al.. (2020). Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age. Clinical Infectious Diseases. 73(7). e1489–e1497. 112 indexed citations
5.
Thompson, Allison, Joseph M. Severs, Ingrid L. Scully, et al.. (2019). Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 37(42). 6201–6207. 77 indexed citations
6.
Østergaard, Lars, Timo Vesikari, Judith Absalon, et al.. (2017). A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. New England Journal of Medicine. 377(24). 2349–2362. 51 indexed citations
7.
Senders, Shelly, Prakash Bhuyan, Qin Jiang, et al.. (2016). Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine. The Pediatric Infectious Disease Journal. 35(5). 548–554. 34 indexed citations
8.
Reiner, David, Prakash Bhuyan, Joseph Eiden, et al.. (2015). Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers. Vaccine. 34(6). 809–813. 11 indexed citations
9.
Bhuyan, Prakash, Joseph Eiden, Thomas R. Jones, et al.. (2014). 1081Immunogenicity of Human Papilloma Vaccine Coadministered with an Investigational Bivalent rLP2086 Vaccine Against Meningococcal Serogroup B in Healthy Adolescents. Open Forum Infectious Diseases. 1(suppl_1). S317–S318. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seyi Eletu Breakdown of academic impact, for papers by Josefina Carlos Breakdown of academic impact, for papers by May ElSherif Breakdown of academic impact, for papers by Magali Traskine Breakdown of academic impact, for papers by Paola Vacca Breakdown of academic impact, for papers by Judith Spijkerman Breakdown of academic impact, for papers by Kumaran Vadivelu Breakdown of academic impact, for papers by Helena Aparecida Barbosa Breakdown of academic impact, for papers by Raydel Anderson Breakdown of academic impact, for papers by Aly Drabo
Rankless by CCL
2026